- Home
- HOWL vs DHAI Comparison
HOWL vs DHAI Comparison
Compare HOWL & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- DHAI
- Stock Information
- Founded
- HOWL 2017
- DHAI 2007
- Country
- HOWL United States
- DHAI United States
- Employees
- HOWL N/A
- DHAI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- DHAI
- Sector
- HOWL Health Care
- DHAI
- Exchange
- HOWL Nasdaq
- DHAI NYSE
- Market Cap
- HOWL 37.9M
- DHAI 49.1M
- IPO Year
- HOWL 2021
- DHAI N/A
- Fundamental
- Price
- HOWL $0.87
- DHAI $0.18
- Analyst Decision
- HOWL Strong Buy
- DHAI
- Analyst Count
- HOWL 3
- DHAI 0
- Target Price
- HOWL $9.00
- DHAI N/A
- AVG Volume (30 Days)
- HOWL 232.7K
- DHAI 1.9M
- Earning Date
- HOWL 05-08-2025
- DHAI 02-14-2025
- Dividend Yield
- HOWL N/A
- DHAI N/A
- EPS Growth
- HOWL N/A
- DHAI N/A
- EPS
- HOWL N/A
- DHAI N/A
- Revenue
- HOWL $1,143,000.00
- DHAI $69,573,000.00
- Revenue This Year
- HOWL N/A
- DHAI N/A
- Revenue Next Year
- HOWL $733.33
- DHAI N/A
- P/E Ratio
- HOWL N/A
- DHAI N/A
- Revenue Growth
- HOWL N/A
- DHAI 5.40
- 52 Week Low
- HOWL $0.60
- DHAI $0.12
- 52 Week High
- HOWL $6.34
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- HOWL 46.85
- DHAI 43.41
- Support Level
- HOWL $0.80
- DHAI $0.16
- Resistance Level
- HOWL $0.97
- DHAI $0.20
- Average True Range (ATR)
- HOWL 0.07
- DHAI 0.03
- MACD
- HOWL 0.02
- DHAI 0.01
- Stochastic Oscillator
- HOWL 41.92
- DHAI 29.58
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.